AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05311371 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control group
Description: No intervention
Study NCT05791474 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATI-2231
Description: Provided by Aclaris Therapeutics, Inc.
Study NCT05582070 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: actigraphy
Description: Actigraphy examination will be performed during 2 periods of 7 days before and after nose nasal desobstruction surgery (septoplasty, septorhinoplasty or total ethmoidectomy). Respectively 2 months before surgery (inclusion) and 4 months after surgery.
Study NCT00062530 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SCBaL/M9
Description: Oral recombinant Salmonella typhi HIV-1 gp120 vaccine
Study NCT06003556 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: PSMA-1007 Positron Emission Tomography (PET) scan
Description: Additional staging PET scan prior to focal therapy to focal therapy.
Study NCT04779255 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Procedure (Tumesent anesthesia)
Description: Photodynamic therapy of vertex with a solution of 180 ml of tumescent anesthesia diffused over 1 hour in three different sub-deceasing points.
Study NCT04779255 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Control Arm (Paracetamol)
Description: Photodynamic therapy of vertex with 1g of paracetamol intake 1 hour before cold water is applied during the session.
Study NCT06155591 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Community Nurse Case Manager (CNCM)
Description: Their action protocol has been designed and sequenced according to the circumstances in which the Complex and Pluripathological Chronic Patient finds themself:~* Pre-hospital discharge. The hospital Nurse Case Manager (HNCM) will contact the CNCM to inform of the imminent hospital discharge.~* Hospital discharge: A comprehensive nursing assessment of the CPCP based on Marjory Gordon's functional patterns will be carried out.~* Planned visits: An infographic will be provided to identify signs and symptoms of decompensation/exacerbation and a direct dial telephone number.~* Proactive telephone follow-up: The CNCM will make comfort calls every week for the first month, every 15 days until the 3-months visit and every month until the 6- and 12-months visits.~* Exacerbations/decompensations: An appointment will be arranged with their Primary Care physician.~* Hospital readmission: The CNCM will be kept informed of the process through the HNCM and CPCP's digital clinical history.
Study NCT06134726 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: seropositivity of rheumatoid factor
Description: All participants were tested for seropositivity of rheumatoid factor and anticitrullinated protein antibodies
Study NCT06371521 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Sportlegs
Description: Sportlegs contains lactate (from calcium lactate pentahydrate and magnesium lactate dihydrate), magnesium (from magnesium lactate dihydrate), calcium (from calcium lactate pentahydrate), and vitamin D (as cholecalciferol).
Study NCT06371521 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Empty Capsules to serve as a placebo control
Study NCT06307054 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: anti-CLL-1 CAR NK cells
Description: Eligible patients enrolled in the study after screening will receive lymphocyte collection(from the patient or a donor ) and receive single dose CLL-1 CAR NK cells infusion after a successful cell production. There are a total of four cell dose level:5×10\^6 CAR-NK cells/kg,1×10\^7CAR-NK cells/kg,2×10\^7CAR-NK cells/kg,4×10\^7CAR-NK cells/kg
Study NCT04927806 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Silver Knight
Description: Silver Knight breathing systems are all validated for up to seven days use, and remain active, in unopened packaging, for up to five years. Silver Knight is proven to help reduce the incidence of MRSA infection and other organisms including:~* Staphyloccus epidermis~* Pseudomonas aeruginosa~* Klebsiella pneumoniae~* Acinetobacter calcoaceticus~* Escherichia coli
Study NCT06040437 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Be-Prox
Description: Be-Prox is an intervention developed to prevent, uncover and handle negative behavior in kindergartens.
Study NCT06321263 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Peripheral Muscle Training and step aerobics training
Description: First 5-minute warm-up in the protocol (calisthenic exercises); 30-40 minutes of resistance exercises and step aerobic exercises and the last 5 minutes cooling (stretching exercises) period will be applied.
Study NCT06321263 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training and step aerobics training
Description: First 5-minute warm-up in the protocol (calisthenic exercises); 30-40 minutes of resistance exercises and step aerobic exercises and the last 5 minutes cooling (stretching exercises) period will be applied.
Study NCT05839210 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LIFE-L Mediterranean Diet
Description: Mediterranean Diet will include goals of: 4+ vegetable servings (2-4 cups) daily, 2+ fruit servings (1.5-2 cups) daily, 2+ whole grain servings daily, 1+ legume serving daily, 1+ serving nuts and seeds daily, and seafood 2 times per week. Limit or avoid highly processed foods, sugar-sweetened beverages and foods, processed meats, red meat, and alcohol.
Study NCT05839210 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LIFE-L Home-Based Exercise Program
Description: The Home-Based Exercise Program will include goals of: 150+ minutes moderate or 75+ minutes vigorous exercise per week, completed in sessions of at least 10-minute duration, including daily aerobic exercise plus two resistance-based exercise sessions per week.
Study NCT05423444 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TF-CBT
Description: evidence-based psychotherapy for trauma in youth
Study NCT05423444 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: TAU
Description: treatment as usual
Study NCT06724146 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sofwave and Pure Impact
Description: The Sofwave System, comprised of an applicator and a console, generates high intensity, non-focused ultrasonic energy which can be delivered percutaneously to tissues.~Pure Impact is an EMS module. This module is wirelessly connected to and controlled by the SofWave console. It functions independently from the existing ultrasound module. Pure Impact generates electrical impulses, which are delivered through electrodes on the skin in direct proximity to the muscles to be stimulated.
Study NCT06713889 — intervention group
Intervention type: BIOLOGICAL
Intervention: Biocollection
Description: At each sampling time, 2 dry tubes of 4 ml, 1 EDTA tube of 4 ml, and 1 heparinised tube of 4 ml, i.e. a total of 16 ml per sampling time.~Group A patients will be sampled at inclusion, before, during and after the TAVI procedure, at 1 month follow-up and at 1 year follow-up, for a total of 120 ml. Patients in groups B and C will be sampled at inclusion, 1 month follow-up, 1 year follow-up and 2 years follow-up, for a total of 80 ml.
Study NCT06713889 — intervention group
Intervention type: BEHAVIORAL
Intervention: Quality of life questionnaires
Description: EQ-5D-5L and HAD questionnaire at inclusion, 1 month follow-up, 1 year follow-up and 2 years follow-up
Study NCT06756646 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention
Description: The aerobic exercise intervention will utilize an ergometer. The program will be conducted 2-3 times per week over a 3-month period.
Study NCT06756646 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Disease and exercise suggestion
Description: The participants will be provided by educational program about COPD self-care and home-based exercise approach.
Study NCT06756646 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Blood flow restriction (BFR) intervention
Description: Blood flow restriction (BFR) intervention will combine aerobic exercise on the ergometer with BFR training. The program will be conducted 2-3 times per week over a 3-month period.
Study NCT06757335 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HP568
Description: In the I/II stage: HP568 administered QD or BID for 28 day cycles.
Study NCT06757335 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HP568 in combination with palbociclib
Description: In the III stage: Daily oral dosages of HP568 for 28 days in combination with palbociclib for 21 days.
Study NCT06758336 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: caffeine
Description: The participants chewing either caffeine Gum (CAF trial, containing 3 mg/kg of caffeine) for 10 minutes. After rested for 15 minutes, the participants underwent tests.
Study NCT06758336 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: caffeine
Description: The participants chewing either caffeine Gum (CAF trial, containing 3 mg/kg of caffeine) for 10 minutes. After rested for 15 minutes, the participants underwent tests.
Study NCT06758284 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laughter Yoga
Description: The first component of the intervention is laughter therapy, which is a combination of warm-up exercises, deep breathing exercises, childlike playfulness and laughter exercises. Participants will do laughter therapy via WhatsApp video call. Laughter yoga will be a single session and will last approximately 30 minutes.
Study NCT06756698 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: conventional treatment plus music intervention
Description: Each music therapy session will include 5 stages. In stage 1, an emotional assessment is conducted to observe the patient's current emotional experience and feelings (provide a VAD score), which lasts about 1 minute. In stage 2, relaxation exercises (breathing relaxation, progressive muscle relaxation, and imaginary relaxation) are conducted under the guidance of the therapist to the music corresponding to the relaxation target VAD, which lasts about 8 minutes. In stage 3, the patient independently selects the music and discusses it with the therapist, which lasts about 10 minutes. In stage 4, the patient listens to resource and positive-oriented music and discusses specific topics with the therapist, which lasts about 10 minutes. Finally, in stage 5, the therapist again conducts an emotional assessment of the patient and observes the patient's current emotional experience and feelings, which lasts about 1 minute.
Study NCT06756698 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional treatment
Description: The conventional treatment group received DBT group therapy 5 times a week, each session lasting 1 hour, and also received individual personalized therapy twice a week.
Study NCT06757309 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mediterranean Diet
Description: Intervention consists in personalized counseling to adopt the Mediterranean diet, focusing on whole foods, healthy fats, and lean proteins. Participants receive tailored meal plans, educational materials, and practical tips. Follow-up sessions at weeks 4 and 12 offer support, progress reviews, and goal-setting to ensure adherence and improved health outcomes
Study NCT06758219 — intervention group
Intervention type: OTHER
Intervention: There is no intervention in the study.
Description: There is no intervention in the study.
Study NCT06758492 — intervention group
Intervention type: DEVICE
Intervention: Video laryngoscopy used to insert thin endotracheal catheter
Description: Video laryngoscopy used to insert thin endotracheal catheter
Study NCT06758492 — intervention group
Intervention type: DEVICE
Intervention: Direct laryngoscopy used to insert thin endotracheal catheter
Description: Direct laryngoscopy used to insert thin endotracheal catheter
Study NCT06758310 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Individualized Exercise
Description: Each participant will be prescribed an individualized exercise program related to their fitness testing results and personal interests.
Study NCT05839210 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Supportive Materials
Description: Participants will receive an informational study notebook, an exercise reference poster and videos, a Fitbit, and three stretch bands of different intensities. Participants will also receive supportive and informational text messages or emails three (3) times per week during the study; participants can opt-out of these messages.~Participants will be requested to utilize the Fitbit app to track exercise sessions, as well as the MyFitnessPal app to track their diet. Support to set up apps will be provided by research staff. For participants who choose not to use the app, a laminated diet and exercise tracking sheet with dry erase marker will be provided, and participants will be advised to send a picture of their completed tracking sheet by text message to research staff each week.
Study NCT05839210 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Supportive Materials
Description: Participants will receive an informational study notebook, an exercise reference poster and videos, a Fitbit, and three stretch bands of different intensities. Participants will also receive supportive and informational text messages or emails three (3) times per week during the study; participants can opt-out of these messages.~Participants will be requested to utilize the Fitbit app to track exercise sessions, as well as the MyFitnessPal app to track their diet. Support to set up apps will be provided by research staff. For participants who choose not to use the app, a laminated diet and exercise tracking sheet with dry erase marker will be provided, and participants will be advised to send a picture of their completed tracking sheet by text message to research staff each week.
Study NCT06758453 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietary Challenge
Description: Ingestion of a high-fat, high-glucose meal to induce postprandial variations in bile acids and other metabolic markers.
Study NCT06199193 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Personalized diet
Description: Personalized supplement designed by artificial intelligence based on the intestinal microbiota and incorporated into diets
Study NCT06199193 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: SHAM_COMPARATOR
Intervention: Dietary counseling
Description: Dietary advice will be provided to adapt the diet to the nutritional objectives and recommended intakes.
Study NCT05277246 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Irrigant concentration
Description: The success of endodontic treatment is directly related to infection control. In successful endodontic treatment, it is necessary to perform an ideal irrigation both in order to gain a better understanding of the complex anatomical structure of the root canals and to increase the efficiency of the instruments and methods used during the canal preparation. Sodium hypochlorite (NaOCl) solution is the standard irrigation agent for cleaning and disinfection of root canal. In this study, the effect of NaOCI on level of IL-8 different concentration will be evaluated.
Study NCT05277246 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: NaOCI
Description: NaOCI
Study NCT05177835 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ABX464
Description: All subjects will receive ABX464 given at 25 mg QD.
Study NCT04740671 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HLX04-O
Description: Biologic recombinant anti-VEGF humanized monoclonal antibody, developed by Shanghai Henlius Biotech, Inc.
Study NCT04740671 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ranibizumab
Description: Biologic anti-VEGF recombinant humanized monoclonal antibody fragment
Study NCT06339801 — intervention group
Intervention type: DEVICE
Intervention: MiVu
Description: All patients will undergo mucosal impedance (MI) measurement using the MiVu™ Mucosal Integrity Testing System (Diversatek Healthcare, Inc.).
Study NCT05786456 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Discussion
Description: Participate in group and web-based self-study sessions
Study NCT05786456 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Informational Intervention
Description: Receive handouts
Study NCT05786456 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Media Intervention
Description: View videos
Study NCT05786456 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT05786456 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telephone-Based Intervention
Description: Participate in check-in calls
Study NCT06436274 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: GARDASIL®9
Description: GARDASIL®9 or equivalent vaccines will be used for this study. These are FDA-approved vaccines.
Study NCT06436274 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: GARDASIL®9
Description: GARDASIL®9 or equivalent vaccines will be used for this study. These are FDA-approved vaccines.
Study NCT06436274 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Menveo®/Menactra®
Description: Menveo®/Menactra® or equivalent vaccines will be used for this study. These are FDA-approved vaccines.
Study NCT06436274 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Menveo®/Menactra®
Description: Menveo®/Menactra® or equivalent vaccines will be used for this study. These are FDA-approved vaccines.
Study NCT06412471 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SSGJ-707
Description: bispecific antibody
Study NCT06412471 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: carboplatin
Description: chemotherapy
Study NCT06412471 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: chemotherapy
Study NCT06412471 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: paclitaxel
Description: chemotherapy
Study NCT06412471 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PD-1/L1
Description: Immune checkpoint inhibitors
Study NCT06412471 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel-albumin
Description: chemotherapy
Study NCT04943133 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Blood pressure measurement and collection of the oscillometric curve for later SFATI analysis
Description: Brachial systolic arterial blood pressure will be systematically taken with acquisition of the oscillometric curve for analysis and measurement with the SFATI system and simultaneous electronic recording of the Korotkoff sound (auscultatory method) and a search for SFATI arterial stiffness markers for all patients. Brachial systolic arterial blood pressure will be measured with the help of a cuff equipped with a Biopac SS30L electronic stethoscope and a MA-300 phonocardiographic microphone, placed side-by-side immediately downstream from the brachial occlusion cuff. The various signals (pneumatic cuff, oscillometric signal and Korotkoff sounds) will be digitalized by an MP35 system.
Study NCT04943133 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Blood pressure measurement with the usual equipment used in the department
Description: Brachial systolic blood pressure will be taken via the conventional oscillometric method, only for hospitalized women. Blood pressure will be measured on the same arm with the help of a conventional Dinamap-type automat (GE), with at least 2 minutes between the end of the first measurement and the start of the second inflation.
Study NCT04943133 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: systematic measurement of pulse wave velocity (aortic and brachial)
Description: Carotid to femoral and carotid to radial pulse wave velocity (Complior) will be systematically determined for hospitalized women and offered to all women seen for consultation.~Pulse wave velocity will be measured with the help of a Complior tonometric system (Alam Medical, Vincennes, France), with which the aorta and the arterial axes of the upper limb used to measure blood pressure can also be measured.
Study NCT06581744 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: [18F]AlF-NOTA-Pentixather
Description: inject 185\~370MBq \[18F\]AlF-NOTA-Pentixather
Study NCT05709379 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sedentary behavior
Description: Interrupting sitting with walking/jogging at either high -or low physical activity intensity.
Study NCT05191875 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saccharomyces Boulardii 250 MG
Description: Saccharomyces Boulardii:~0.25 g \* 6, Produced by The French encyclopedia pharmaceutical Factory
Study NCT05191875 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Ilaprazole.Doxycycline. Furazolidone. Colloidal Bismuth Tartrate
Description: Ilaprazole:~5mg\*6, produced by Livzon Pharmaceutical Group Inc~Doxycycline:~0.1 g \* 10, produced by Jiangsu Yongxin Ltd.~Furazolidone:~0.1g\*100 produced by Tianjin Lisheng Pharmaceutical Co., LTD~Colloidal Bismuth Tartrate:~55 mg \* 36,produced by Shanxi Xinbaoyuan Pharmaceutical Co., LTD